Mechanism of Action of a Novel Latent Membrane Protein-1 Dominant Negative
Open Access
- 1 January 2001
- journal article
- Published by Elsevier BV
- Vol. 276 (2), 1195-1203
- https://doi.org/10.1074/jbc.m005461200
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- STATs in oncogenesisOncogene, 2000
- Epstein–Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regionsOncogene, 1998
- Epstein–Barr virus: LMP1 masquerades as an active receptorCurrent Biology, 1998
- Localization of the Major NF-κB-activating Site and the Sole TRAF3 Binding Site of LMP-1 Defines Two Distinct Signaling MotifsPublished by Elsevier BV ,1997
- Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell DeathCell, 1996
- Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and HLA‐class I antigen expressionEuropean Journal of Immunology, 1995
- The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domainCell, 1993
- Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell deathCell, 1991
- Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.The Journal of Experimental Medicine, 1988
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell, 1985